Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gary D. Krzyzanowski"'
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208508 (2018)
This study was undertaken to evaluate a novel method for stabilizing and preserving the original proportion of cell-free fetal DNA (cffDNA) in maternal blood for extended periods of time without using crosslinking agents, such as formaldehyde, which
Externí odkaz:
https://doaj.org/article/0e884f8b0ac74be5be445bd065d5a3c8
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183915 (2017)
Cell-free DNA (cfDNA) in blood is used as a source of genetic material for noninvasive prenatal and cancer diagnostic assays in clinical practice. Recently we have started a project for new biomarker discovery with a view to developing new noninvasiv
Externí odkaz:
https://doaj.org/article/6c38870b9cb94396a4e5aeabdfce731a
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 483
Background Plasma cell-free DNA (cfDNA) fragment size distribution provides important information required for diagnostic assay development. We have developed and optimized droplet digital PCR (ddPCR) assays that quantify short and long DNA fragments
Publikováno v:
Journal of Diabetes Science and Technology. 6:483-485
Research shows lifestyle changes and regular monitoring of diabetes indices are the most effective means to manage diabetes.1,2 Measuring hemoglobin A1c (A1C) is an accepted means of diagnosis and a helpful indicator when monitoring diabetes status.
Autor:
Kausik Das, M. Rohan Fernando, Jodi R. Alt, Gary D. Krzyzanowski, Sheila E. Norton, Thomas Williams
Publikováno v:
Molecular Diagnosis & Therapy
Background Messenger RNA (mRNA) expression levels in blood cells are important in disease diagnosis, prognosis and biomarker discovery research. Accurate measurements of intracellular mRNA levels in blood cells depend upon several pre-analytical fact